Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Dyax

Dyax?uq=oeHSfu7P
1995 FOUNDED
M&A STATUS
201-300 EMPLOYEES
M&A LATEST DEAL TYPE
$6.5B LATEST DEAL AMOUNT
Description

Developer of biopharmaceuticals for oncology and inflammatory indications. The company offers drug discovery technology, known as phage display to identify antibody, small protein and peptide compounds for clinical development and provides chromatography separations systems and products that are used in laboratories and pharmaceutical manufacturing to separate molecules in liquid mixtures.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Primary Office
  • 55 Network Drive
  • Burlington, MA 01803
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Dyax’s full profile, request a free trial.

Dyax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 22-Jan-2016 $6.5B 000.00 00.00 Completed Generating Revenue
11. PIPE 02-Nov-2015 000.00 Completed Generating Revenue
10. PIPE 13-May-2013 0000 000.00 Completed Generating Revenue
9. PIPE 01-Jan-2012 000.00 Completed Generating Revenue
8. PIPE 01-Jan-2009 000.00 Completed Generating Revenue
7. PIPE 01-Jan-2008 000.00 Completed Generating Revenue
6. PIPE 01-Aug-2006 000.00 Completed Generating Revenue
5. PIPE 14-Mar-2003 00.000 000.00 Completed Generating Revenue
4. IPO 15-Aug-2000 $60M $44.5M 00000 Completed Generating Revenue
3. Later Stage VC 16-Nov-1998 $31M $44.5M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Dyax Former Investors (27)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alta Partners Venture Capital Minority 000 0000 000000 0
Baker Bros. Advisors Limited Partner Minority 000 0000 000000 0
BancBoston Capital PE/Buyout Minority 000 0000 000000 0
BancBoston Ventures Venture Capital Minority 000 0000 000000 0
Federated Investors and Affiliates Corporation Minority 000 0000 000000 0
You’re viewing 5 of 27 investors. Get the full list »